Physician profile
Bret M Johnson
NPI 1770560153
$3,298.10
in general payments reported to CMS, 2019-2025
20 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $435 · 2021: $654 · 2022: $738 · 2023: $481 · 2024: $441 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $970 · Education: $91.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $970.15 |
| Education | $91.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $980.27 | 2019-2024 | |
| Abbvie INC. | $953.83 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $259.66 | 2019-2023 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $158.73 | 2022-2023 | Tremfya |
| Ucb, INC. | $144.87 | 2019-2022 | |
| Amgen INC. | $135.08 | 2019-2022 | |
| Pfizer INC. | $123.09 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $111.11 | 2019 | |
| Genzyme Corporation | $107.37 | 2020-2023 | |
| Lilly USA, LLC | $70.27 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $55.14 | 2020-2022 | |
| Leo Pharma INC. | $49.94 | 2020-2022 | |
| Convatec INC. | $31.93 | 2023 | |
| Paratek Pharmaceuticals, INC. | $21.42 | 2022 | |
| Celgene Corporation | $21.20 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $19.92 | 2020 | |
| Kyowa Kirin, INC. | $17.13 | 2020 | |
| Merck Sharp & Dohme LLC | $13.16 | 2019 | |
| Organon LLC | $12.02 | 2025 | Vtama |
| Helsinn Therapeutics (U.S.), INC. | $11.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.